comparemela.com

Latest Breaking News On - Endocrine diseases - Page 1 : comparemela.com

Crinetics Pharmaceuticals Inc s Chief Scientific Officer Sells Company Shares

On January 25, 2024, Stephen Betz, Chief Scientific Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), sold 3,000 shares of the company.

Crinetics Pharmaceuticals Inc Insider Sells Shares

Chief Scientific Officer Stephen Betz of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 3,000 shares of the company on January 10, 2024, according to a recent SEC Filing.

Insider Sell: Chief Med and Dev Officer Dana Pizzuti Sells 14,375 Shares of Crinetics

Chief Med and Dev Officer Dana Pizzuti of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 14,375 shares of the company on January 3, 2024, according to a recent SEC filing.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.